Enantioselective penetration enhancing effect of carvone on the in vitro transdermal permeation of nicorandil

Pharmaceutical Development and Technology

Volumn 17, Issue 5, 2012, Pages 574-582

  Krishnaiah, Yellela S R ^a,b   Nada, Aly ^b  

^a NOVA SOUTHEASTERN UNIVERSITY   (United States)

^b KUWAIT UNIVERSITY   (Kuwait)

Author keywords

Carvone; Enantiomers; Enantioselective; In vitro permeation; Rat epidermis; Transdermal

Indexed keywords

CARVONE; HYDROXYPROPYLMETHYLCELLULOSE; LIPID; NICORANDIL; PROTEIN;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DIFFERENTIAL SCANNING CALORIMETRY; DRUG DELIVERY SYSTEM; DRUG PENETRATION; ENANTIOMER; ENANTIOSELECTIVITY; EPIDERMIS; GEL; IN VITRO STUDY; INFRARED SPECTROSCOPY; MALE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; RAT; STEADY STATE; STRATUM CORNEUM;

ADMINISTRATION, CUTANEOUS; ANIMALS; EPIDERMIS; ISOMERISM; MALE; MONOTERPENES; NICORANDIL; PHARMACEUTICAL VEHICLES; RATS; SKIN ABSORPTION; VASODILATOR AGENTS;

EID: 84865323321     PISSN: 10837450     EISSN: 10979867     Source Type: Journal    
DOI: 10.3109/10837450.2011.557729     Document Type: Article

References (57)

1. McIntosh TJ, Stewart ME, Downing DT. X-ray diffraction analysis of isolated skin lipids: reconstitution of intercellular lipid domains. Biochemistry 1996;35:3649-3653. (Pubitemid 26102151)
2. Elias PM. Epidermal lipids, membranes, and keratinization. Int J Dermatol 1981;20:1-19. (Pubitemid 11127961)
3. Williams ML, Elias PM. The extracellular matrix of stratum corneum: role of lipids in normal and pathological function. Crit Rev Ther Drug Carrier Syst 1987;3:95-122. (Pubitemid 17219200)
4. Heard CM, Brain KR. Does solute stereochemistry influence percutaneous penetration? Chirality 1995;7:305-309.
5. Afouna MI, Fincher TK, Khan MA, Reddy IK. Percutaneous permeation of enantiomers and racemates of chiral drugs and prediction of their flux ratios using thermal data: a pharmaceutical perspective. Chirality 2003;15:456-465. (Pubitemid 36523135)
6. Nerurkar SG, Dighe SV, Williams RL. Bioequivalence of racemic drugs. J Clin Pharmacol 1992;32:935-943.
7. Reddy IK, Kommuru TR, Zaghloul AA, Khan MA. Chirality and its implications in transdermal drug development. Crit Rev Ther Drug Carrier Syst 2000;17:285-325. (Pubitemid 30644097)
8. Bodhibukkana C, Srichana T, Kaewnopparat S, Tangthong N, Bouking P, Martin GP et al. Composite membrane of bacteriallyderived cellulose and molecularly imprinted polymer for use as a transdermal enantioselective controlled-release system of racemic propranolol. J Control Release 2006;113:43-56. (Pubitemid 43818158)
9. Miyazaki K, Kaiho F, Inagaki A, Dohi M, Hazemoto N, Haga M et al. Enantiomeric difference in percutaneous penetration of propranolol through rat excised skin. Chem Pharm Bull 1992;40:1075-1076.
10. Zahir A, Kunta JR, Khan MA, Reddy IK. Effect of menthol on permeability of an optically active and racemic propranolol across guinea pig skin. Drug Dev Ind Pharm 1998;24:875-878. (Pubitemid 28413437)
11. Suedee R, Bodhibukkana C, Tangthong N, Amnuaikit C, Kaewnopparat S, Srichana T. Development of a reservoir-type transdermal enantioselective- controlled delivery system for racemic propranolol using a molecularly imprinted polymer composite membrane. J Control Release 2008;129:170-178.
12. Suedee R, Brain KR, Heard CM. Differential permeation of propranolol enantiomers across human skin in vitro from formulations containing an enantioselective excipient. Chirality 1999;11:680-683. (Pubitemid 29496534)
13. Kommuru TR, Khan MA, Reddy IK. Racemate and enantiomers of ketoprofen: phase diagram, thermodynamic studies, skin permeability, and use of chiral permeation enhancers. J Pharm Sci 1998;87:833-840. (Pubitemid 28319413)
14. Kommuru TR, Khan MA, Reddy IK. Effect of chiral enhancers on the permeability of optically active and racemic metoprolol across hairless mouse skin. Chirality 1999;11:536-540. (Pubitemid 29344476)
15. Roy SD, Chatterjee DJ, Manoukian E, Divor A. Permeability of pure enantiomers of ketorolac through human cadaver skin. J Pharm Sci 1995;84:987-990.
16. Roy SD, Manoukian E, Combs D. Absorption of transdermally delivered ketorolac acid in humans. J Pharm Sci 1995;84:49-52. (Pubitemid 26066009)
17. Zobrist RH, Schmid B, Feick A, Quan D, Sanders SW. Pharmacokinetics of the R-and S-enantiomers of oxybutynin and N-desethyloxybutynin following oral and transdermal administration of the racemate in healthy volunteers. Pharm Res 2001;18:1029-1034. (Pubitemid 32799951)
18. Zeng A, Wang C, Yuan B, Yang G, Fu Q. The influence of chirality, physicochemical properties, and permeation enhancers on the transdermal permeation of amlodipine across rat skin. Drug Dev Ind Pharm 2010;36:724-734.
19. Touitou E, Chow DD, Lawter JR. Chiral beta-blockers for transdermal delivery. Int J Pharm 1994;104:19-28.
20. Williams AC, Barry BW. Penetration enhancers. Adv Drug Deliv Rev 2004;56:603-618. (Pubitemid 38326936)
21. Krishnaiah YS, Al-Saidan SM, Chandrasekhar DV, Satyanarayana V. Bioavailability of nerodilol-based transdermal therapeutic system of nicorandil in human volunteers. J Control Release 2005;106:111-122. (Pubitemid 41140086)
22. Krishnaiah YS, Satyanarayana V, Bhaskar P. Influence of menthol and pressure-sensitive adhesives on the in vivo performance of membrane-moderated transdermal therapeutic system of nicardipine hydrochloride in human volunteers. Eur J Pharm Biopharm 2003;55:329-337. (Pubitemid 36561560)
23. Krishnaiah YS, Bhaskar P, Satyanarayana V. Penetration-enhancing effect of ethanol-water solvent system and ethanolic solution of carvone on transdermal permeability of nimodipine from HPMC gel across rat abdominal skin. Pharm Dev Technol 2004;9:63-74. (Pubitemid 38250227)
24. Krishnaiah YS, Rama B, Raghumurthy V, Ramanamurthy KV, Satyanarayana V. Effect of PEG6000 on the in vitro and in vivo transdermal permeation of ondansetron hydrochloride from EVA1802 membranes. Pharm Dev Technol 2009;14:50-61.
25. Cornwell PA, Barry BW, Stoddart CP, Bouwstra JA. Wideangle X-ray diffraction of human stratum corneum: effects of hydration and terpene enhancer treatment. J Pharm Pharmacol 1994;46:938-950.
26. Gao S, Singh J. In vitro percutaneous absorption enhancement of a lipophilic drug tamoxifen by terpenes. J Control Release 1998;51:193-199. (Pubitemid 28252871)
27. Mackay KM, Williams AC, Barry BW. Effect of melting point of chiral terpenes on human stratum corneum uptake. Int J Pharm 2001;228:89-97. (Pubitemid 32905368)
28. Frampton J, Buckley MM, Fitton A. Nicorandil. A review of its pharmacology and therapeutic efficacy in angina pectoris. Drugs 1992;44:625-655.
29. Kerins DM, Robertson RM, Robertson D. Drugs used for the treatment of myocardial ischemia. In: Hardman JG, Limbird LE, eds. Goodman and Gilman's the Pharmacological Basis of Therapeutics. New York: McGraw Hill Medical Publishing Division, 2001, pp 864.
30. Frydman A. Pharmacokinetic profile of nicorandil in humans: an overview. J Cardiovasc Pharmacol 1992;20 Suppl 3:S34-S44.
31. Krishnaiah YS, Chandrasekhar DV, Rama B, Jayaram B, Satyanarayana V, Al-Saidan SM. In vivo evaluation of limonenebased transdermal therapeutic system of nicorandil in healthy human volunteers. Skin Pharmacol Physiol 2005;18:263-272. (Pubitemid 41527616)
32. Krishnaiah YS, Al-Saidan SM, Chandrasekhar DV, Satyanarayana V. Controlled in vivo release of nicorandil from a carvone-based transdermal therapeutic system in human volunteers. Drug Deliv 2006;13:69-77. (Pubitemid 43087623)
33. Tipre DN, Vavia PR. Formulation optimization and stability study of transdermal therapeutic system of nicorandil. Pharm Dev Technol 2002;7:325-332. (Pubitemid 34983124)
34. Krishnaiah YS, Al-Saidan SM, Chandrasekhar DV, Rama B. Effect of nerodilol and carvone on in vitro permeation of nicorandil across rat epidermal membrane. Drug Dev Ind Pharm 2006;32:423-435.
35. Krishnaiah YS, Bhaskar P, Satyanarayana V. Effect of carvone on the permeation of nimodipine from a membrane-moderated transdermal therapeutic system. Pharmazie 2003;58:559-563. (Pubitemid 37012237)
36. Simon GA, Maibach HI. Relevance of hairless mouse as an experimental model of percutaneous penetration in man. Skin Pharmacol Appl Skin Physiol 1998;11:80-86. (Pubitemid 28266316)
37. Ohkura K, Hori H. Analysis of structure-permeability correlation of nitrophenol analogues in newborn rat abdominal skin using semiempirical molecular orbital calculation. Bioorg Med Chem 1999;7:309-314. (Pubitemid 29117093)
38. dos Anjos JL, de Sousa Neto D, Alonso A. Effects of ethanol/lmenthol on the dynamics and partitioning of spin-labeled lipids in the stratum corneum. Eur J Pharm Biopharm 2007;67:406-412. (Pubitemid 47211894)
39. Al-Saidan SM. Transdermal self-permeation enhancement of ibuprofen. J Control Release 2004;100:199-209. (Pubitemid 39491272)
40. Fluhr JW, Mao-Qiang M, Brown BE, Hachem JP, Moskowitz DG, Demerjian M et al. Functional consequences of a neutral pH in neonatal rat stratum corneum. J Invest Dermatol 2004;123:140-151. (Pubitemid 38833475)
41. Zhao K, Singh J. In vitro percutaneous absorption enhancement of propranolol hydrochloride through porcine epidermis by terpenes/ethanol. J Control Release 1999;62:359-366. (Pubitemid 29476583)
42. Krishnaiah YS, Bhaskar P, Satyanarayana V. In vitro percutaneous permeability enhancement of nimodipine by limonene across the excised rat abdominal skin. Pharmazie 2004;59:942-947. (Pubitemid 39664494)
43. Wang MY, Yang YY, Heng PW. Role of solvent in interactions between fatty acids-based formulations and lipids in porcine stratum corneum. J Control Release 2004;94:207-216. (Pubitemid 37542390)
44. Scheuplein RJ, Blank IH. Permeability of the skin. Physiol Rev 1971;51:702-747.
45. Casal HL, Mantsch HH. Polymorphic phase behaviour of phospholipid membranes studied by infrared spectroscopy. Biochim Biophys Acta 1984;779:381-401.
46. Bouwstra JA, Dubbelaar FE, Gooris GS, Weerheim AM, Ponec M. The role of ceramide composition in the lipid organisation of the skin barrier. Biochim Biophys Acta 1999;1419:127-136. (Pubitemid 29322704)
47. Obata Y, Utsumi S, Watanabe H, Suda M, Tokudome Y, Otsuka M et al. Infrared spectroscopic study of lipid interaction in stratum corneum treated with transdermal absorption enhancers. Int J Pharm 2010;389:18-23.
48. Cornwell PA, Barry BW. Sesquiterpene components of volatile oils as skin penetration enhancers for the hydrophilic permeant 5-fluorouracil. J Pharm Pharmacol 1994;46:261-269. (Pubitemid 24111129)
49. Brandts JF, Hu CQ, Lin LN, Mos MT. A simple model for proteins with interacting domains. Applications to scanning calorimetry data. Biochemistry 1989;28:8588-8596.
50. Golden GM, Guzek DB, Harris RR, McKie JE, Potts RO. Lipid thermotropic transitions in human stratum corneum. J Invest Dermatol 1986;86:255-259. (Pubitemid 16124158)
51. El-Kattan AF, Asbill CS, Michniak BB. The effect of terpene enhancer lipophilicity on the percutaneous permeation of hydrocortisone formulated in HPMC gel systems. Int J Pharm 2000;198:179-189. (Pubitemid 30184855)
52. Hornok L (ed.). Cultivation and Processing of Medicinal Plants. John Wiley & Sons, Chichester, UK, 1992.
53. Leitereg TJ, Guadagni DG, Harris J, Mon TR, Teranishi R. Evidence for the difference between the odours of the optical isomers (4)-and (-)-carvone. Nature 1971;230:455-456.
54. Moffat AC, Osselton MD, Widdop B (eds). Clarke's Analysis of Drugs and Poisons in Pharmaceuticals, Body Fluids, and Postmortem Materials. Pharmaceutical Press, London, 2004, pp 1332-1333.
55. Moghimi HR, Williams AC, Barry BW. A lamellar matrix model for stratum corneum intercellular lipids.5. Effects of terpene penetration enhancers on the structure and thermal behaviour of the matrix. Int J Pharm 1997;146:41-54. (Pubitemid 27062963)
56. Hori M, Satoh S, Maibach HI, Guy RH. Enhancement of propranolol hydrochloride and diazepam skin absorption in vitro: effect of enhancer lipophilicity. J Pharm Sci 1991;80:32-35.
57. Zhang CF, Yang ZL, Luo JB. Effects of enantiomer and isomer permeation enhancers on transdermal delivery of ligustrazine hydrochloride. Pharm Dev Technol 2006;11:417-424.